Hermina Novida, - and Soebagijo Adi Soelistijo, - and Ari Sutjahjo, - (2021) Soluble CD163 and small dense LDL cholesterol levels in type 2 diabetes patients. Gaceta Médica de Caracas, 129 (2s). s305-s312. ISSN 0367-4762

	Text (artikel) C-06 Artikel.pdf Download (259kB)
	Text (karil) C-06 karil.pdf Download (191kB)
	Text (korespponding) C-06 Koresponding.pdf Download (187kB)
	Text (turnitin) C-06 turnitin.pdf Download (1MB)

Abstract

Introduction: The sdLDL cholesterol proportion is a better marker for the prediction of cardiovascular diseases (CVDs). Macrophages play a crucial role in both initiation and progression of atherosclerosis, the underlying mechanism of CVDs. This study investigated the correlation between soluble CD163 as a biomarker macrophage activation and sdLDL cholesterol in type 2 diabetes mellitus (T2DM) subjects for the first time. Methods: This study was an observational analytic cross-sectional study involved 40 patients with T2DM in Surabaya, Indonesia. The sdLDL was measured using a direct enzymatic colorimetric method using Architect c8000. The levels of sCD163 were measured by a quantitative enzyme immunoassay technique using a specific monoclonal antibody for human CD163 using Quantikine Elisa produced by R&D Systems Inc., USA. Results: The average level of HbA1c in this study was 8.01 ± 1.39 %, and more than half of the subjects had HbA1c levels >8 % that revealed most of the patients in this study were in poor glycemic control. The average sdLDL cholesterol level in this study was 40.80 ± 19.14 mg/dL, and the mean of soluble CD163 was 741.22 ± 41.55 ng/mL. There were no differences in gender (male or female), glycemic control (<8 % vs >8 %), hypertension, and smoking on sCD163 levels and sdLDL cholesterol levels. We found a positive correlation between the soluble CD163 level with sdLDL (r=0.440, p=0.004). Conclusion: The atherogenic lipoprotein fraction sdLDL cholesterol level correlated with soluble CD163 level. This could be a new link between lipid dysregulation, innate immunity, and atherosclerosis in T2DM.

Actions (login required)

View Item